BPBT
BIIB icon

Boston Private Bank & Trust’s Biogen BIIB Stock Holding History

Boston Private Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.79M Buy
4,252
+880
+26% +$347K 0.08% 192
2014
Q4 		$1.15M Buy
3,372
+17
+0.5% +$5.5K 0.05% 226
2014
Q3 		$1.11M Buy
3,355
+20
+0.6% +$6.59K 0.05% 228
2014
Q2 		$1.05M Sell
3,335
-5
-0.1% -$1.5K 0.05% 231
2014
Q1 		$1.02M Buy
3,340
+10
+0.3% +$3.17K 0.05% 237
2013
Q4 		$931K Buy
3,330
+117
+4% +$30.3K 0.05% 239
2013
Q3 		$774K Sell
3,213
-633
-16% -$142K 0.04% 248
2013
Q2 		$828K Buy
+3,846
New +$822K 0.05% 237

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Boston Private Bank & Trust's BIIB Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Biogen (BIIB) stake by 26% in Q1 2015, buying an estimated $347K and bringing the position to 4,252 shares worth $1.79M. The position accounts for 0.08% of the portfolio, ranked #192.

Boston Private Bank & Trust first reported a position in BIIB in Q2 2013 and has held it in 8 quarters since. 967 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • Boston Private Bank & Trust held 4,252 shares of Biogen worth $1.79M as of Q1 2015.
  • Boston Private Bank & Trust bought 880 Biogen shares in Q1 2015, an estimated $347K.
  • Biogen made up 0.08% of Boston Private Bank & Trust's portfolio in Q1 2015, its #192 holding.
  • Boston Private Bank & Trust first reported a position in Biogen in Q2 2013 and has held it in 8 quarters since.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.